As of 2014, the firm seems to have ceased operations. Calibrant Biosystems, Inc., a biotechnology company, had been engaged in the discovery and development of protein drug targets and markers for the treatment and diagnosis of diseases. Offers various therapeutics, protein drug targets, disease pathways, and biomarkers from microdissected human tissue specimens., the company provided therapeutics across a range of cancer indications, including ovarian and primary brain cancer
